XFOR (X4 Pharmaceuticals) Short-Term Debt to Capital
Partner plants ensure the uninterrupted production and packaging of medications, while logistics automation eliminates any delays. This daily price chart for X4 Pharmaceuticals (XFOR) demonstrates the asset's dynamics, with a value of 0.00. The business relies on creating proprietary patented CXCR4 blocking solutions for the therapy of rare pathologies, while also developing cooperation with specialized clinics and suppliers to deliver innovative bone marrow treatment.
Analytical breakdowns for X4 Pharmaceuticals
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital X4 Pharmaceuticals|XFOR - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio X4 Pharmaceuticals, Inc.|XFOR - Aggregate Debt Obligations|Debts to Book Capitalization X4 Pharmaceuticals Inc.|XFOR - Long-Term Debt Volume|Company Short-Term Debt X4 Pharmaceuticals|Quick Liquidity x4pharma.com
- company profitability and valuation multiples indicators:
Fundamental valuation:X4 Pharma
The commercialization of Xolremdi and the expansion of neutropenia therapy require precise liquidity management to support operational growth. The dynamics of current debt to equity reflect the ratio of short-term liabilities to net assets, allowing investors to assess the risk of credit overload and the balance sheet resilience of X4 Pharmaceuticals (XFOR) in the face of market shocks, which directly impacts the company's final capitalization.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV: Short-Term Debt to Equity Ratio|SEPN (Septerna Pharma) - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital Ratio Pieris Pharmaceuticals|Short-Term Debt to Equity Ratio savarapharma.com|RIGL - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity ANAB|ATXS - Current Liabilities to Equity|Short-Term Debt to Capital enGene Corp (ENGN)|Ratio of Short-Term Indebtedness to Capital RAPT Therapeutics|Short-Term Debt to Capital Aerovate Therapeutics, Inc. JBIO|Aclaris Therapeutics, Inc. - Short-Term Debt to Capital|KYTX: Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Tiziana Life Sciences PLC TLSA|CABA (Cabaletta Bio Inc) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio VTYX|Short-Term Debt to Capital theratech.com|Short-Term Debt to Capital AVTX|Short-Term Debt to Capital Eledon Pharmaceuticals Inc. (ELDN)|Agenus Inc - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Climb Bio, Inc CLYM|ZURA (Zura Bio) - Current Liabilities to Capital|atyrpharma.com (ATYR) - Short-Term Debt to Equity Ratio|ADAG: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Ikena Oncology|Shattuck Labs Inc (STTK) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital Equillium Bio|CNTB (Connect Biopharma) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital immunic-therapeutics.com (IMUX)|Atara Bio - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital InflaRx NV IFRX|Adicet - Short-Term Debt to Capital|CELU: Short-Term Debt to Equity|INmune Bio, Inc. (INMB) - Short-Term Debt to Equity|BRNS (barinthusbio.com) - Short-Term Debt to Equity|KZR: Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio SAB Biotherapeutics Inc. (SABS)|Short-Term Debt to Capital Ratio Akari Therapeutics plc AKTX|Short-Term Debt to Capital enlivex.com (ENLV)|Q32 Bio (QTTB) - Current Liabilities to Equity|geovax.com - Short-Term Debt to Equity|EDSA (Edesa Biotech) - Current Liabilities to Capital|IBIO: Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital carismatx.com CARM|XTLB (XTL Bio) - Short-Term Debt to Equity|Current Liabilities to Equity Bolt Biotherapeutics Inc. BOLT|Short-Term Debt to Capital HCW Biologics Inc|Aptevo Therapeutics (APVO) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital aimimmuno.com (AIM)|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|GRI Bio Corporation - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XORTX Therapeutics Inc. (XRTX)|HIND: Short-Term Debt to Equity|REVB (Revelation Biosciences, Inc.) - Short-Term Debt to Equity Ratio|Indaptus Therapeutics Inc (INDP) - Short-Term Debt to Capital|SCNI (Scinai) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Affimed (AFMD) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital allakos.com (ALLK)|Short-Term Debt to Capital Coefficient HOOK|IGM Biosciences Inc. - Short-Term Debt to Equity|ITOS: Short-Term Debt to Equity Ratio|OCEA: Short-Term Debt to Equity|TCBP (TC Biopharm) - Short-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio thirdharmonicbio.com